HIGHLIGHTS
- who: Xinyi Cao from the Study approval The study was designed and conducted in accordance with Chinese law and the criteria set by the Declaration of HelsinkiThe protocol concerning the use of patient samples in this study was approved by the Biomedical Research Ethics Committee of Peking University First Hospital (approval number:, [1280]), and informed consent was obtained from all participants. All mouse experiments were approved by the Ethical Committee of Tianjin Medical University (permit no. SYXK:, ). KPMP approved the KPMP data usage in our study. The results of human AKI scRNA-seq in this study are . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.